Fletcher Aaron G.L.

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$10.96M
Insider Sells Quantity
9
Insider Sells Sum
$3.15M

Insider Activity of Fletcher Aaron G.L.

According to the SEC Form 4 filings, Fletcher Aaron G.L., being in a position of

  1. 10 percent owner at Lantern Pharma Inc.,
    оver the last 12 months, has bought 0 shares, and sold 232889 shares for $1.11M,
    over all time since 2022-11-08, has bought 0 shares, and sold 728237 shares for $3.15M.

The largest purchase of all time was on 2021-10-13 and amounted to 380000 shares of Cognition Therapeutics, Inc. for $4.56M.

The largest sale of all time was on 2022-11-08 and amounted to 350000 shares of Lantern Pharma Inc. for $1.54M.

Biography of Fletcher Aaron G.L.

No biography is available at this moment.

2024-05-24SaleLantern Pharma Inc.
LTRN
10 percent owner
20,000
0.1889%
$6.33$126,600-39.08%
2024-05-23SaleLantern Pharma Inc.
LTRN
10 percent owner
10,000
0.0932%
$6.25$62,500-37.21%
2024-02-29SaleLantern Pharma Inc.
LTRN
10 percent owner
19,703
0.1653%
$4.87$95,954-7.59%
2024-02-28SaleLantern Pharma Inc.
LTRN
10 percent owner
74,297
0.6556%
$4.85$360,340-12.75%
2024-02-27SaleLantern Pharma Inc.
LTRN
10 percent owner
50,000
0.4668%
$4.40$220,000-0.78%
2024-01-17SaleLantern Pharma Inc.
LTRN
10 percent owner
58,889
0.6101%
$4.20$247,334+10.89%
2023-11-29SaleLantern Pharma Inc.
LTRN
10 percent owner
145,348
1.1501%
$3.44$499,997+7.42%
2023-06-21PurchaseAzitra, Inc.
AZTR
10 percent owner
2.3M
–
$3.15$7.24M-73.83%
2022-12-12PurchaseIN8bio, Inc.
INAB
director
75,001
0.359%
$2.48$185,912-44.94%
2022-11-28PurchaseCognition Therapeutics, Inc.
CGTX
director
16,064
0.0706%
$2.65$42,565-31.76%
2022-11-16PurchaseCognition Therapeutics, Inc.
CGTX
director
71,000
0.3069%
$1.40$99,400+27.37%
2022-11-15PurchaseCognition Therapeutics, Inc.
CGTX
director
1.5M
5.2511%
$1.20$1.8M+20.34%
2022-11-08SaleLantern Pharma Inc.
LTRN
director
350,000
3.233%
$4.40$1.54M+13.9%
2022-09-28PurchaseIN8bio, Inc.
INAB
25,000
0.1111%
$2.02$50,535-18.57%
2022-05-23PurchaseCue Biopharma, Inc.
CUE
55,000
0.1455%
$3.34$183,700-12.61%
2022-03-31PurchaseCue Biopharma, Inc.
CUE
735,000
2.0277%
$4.76$3.5M-36.07%
2021-10-13SaleCognition Therapeutics, Inc.
CGTX
director
180.56
0.0034%
$12.00$2,167-76.39%
2021-10-13PurchaseCognition Therapeutics, Inc.
CGTX
director
380,000
7.2005%
$12.00$4.56M-76.39%
2020-11-24PurchaseCue Biopharma, Inc.
CUE
director
13,096
0.0466%
$12.64$165,552+4.77%
2020-06-24PurchaseCue Biopharma, Inc.
CUE
director
15,000
0.0552%
$24.88$373,144-42.7%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.